Who owns PALVELLA THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PVLA from SEC Form 13F filings across 196 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 196 institutions disclosed 14.1M shares of PALVELLA THERAPEUTICS, INC. worth $2.15B — about 98.2% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
196
13F holders
$2.15B
value, 2026 filers
98.2%
of shares outstanding (14.1M sh)
37
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PVLA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 1.1M | $173.5M | 3.2% | 7.9% | -1.6% |
| 2 | JENNISON ASSOCIATES LLC | 960,619 | $146.8M | 0.1% | 6.7% | +50.0% |
| 3 | BlackRock, Inc. | 918,357 | $140.3M | 0.0% | 6.4% | +33.7% |
| 4 | Frazier Life Sciences Management, L.P. | 882,400 | $134.8M | 2.9% | 6.1% | 0.0% |
| 5 | First Light Asset Management, LLC | 771,901 | $118.0M | 7.2% | 5.4% | -21.3% |
| 6 | BVF INC/IL | 672,789 | $102.8M | 2.6% | 4.7% | -30.0% |
| 7 | STATE STREET CORP | 653,172 | $99.8M | 0.0% | 4.5% | +42.3% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 638,868 | $97.6M | 0.0% | 4.5% | +58.7% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 513,794 | $78.5M | 0.0% | 3.6% | +7.6% |
| 10 | FRONTIER CAPITAL MANAGEMENT CO LLC | 478,833 | $73.2M | 0.7% | 3.3% | +28.0% |
| 11 | FEDERATED HERMES, INC. | 433,015 | $66.2M | 0.1% | 3% | 0.0% |
| 12 | Woodline Partners LP | 317,517 | $48.5M | 0.1% | 2.2% | 0.0% |
| 13 | ORBIMED ADVISORS LLC | 292,360 | $44.7M | 0.8% | 2% | +117.2% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 276,164 | $42.2M | 0.0% | 1.9% | +34.3% |
| 15 | Siren, L.L.C. | 257,485 | $39.3M | 0.8% | 1.8% | 0.0% |
| 16 | PRIMECAP MANAGEMENT CO/CA/ | 256,182 | $39.1M | 0.0% | 1.8% | +31.4% |
| 17 | ALLIANCEBERNSTEIN L.P. | 253,168 | $31.6M | 0.0% | 1.8% | -3.7% |
| 18 | EVENTIDE ASSET MANAGEMENT, LLC | 231,484 | $35.4M | 0.5% | 1.6% | -0.8% |
| 19 | EMERALD ADVISERS, LLC | 229,486 | $35.1M | 0.8% | 1.6% | +42.1% |
| 20 | FMR LLC | 214,841 | $32.8M | 0.0% | 1.5% | -0.4% |
| 21 | MPM BIOIMPACT LLC | 204,027 | $31.2M | 1.9% | 1.4% | -1.2% |
| 22 | GOLDMAN SACHS GROUP INC | 201,514 | $30.8M | 0.0% | 1.4% | +3.8% |
| 23 | MORGAN STANLEY | 181,428 | $27.7M | 0.0% | 1.3% | +41.8% |
| 24 | First Turn Management, LLC | 156,450 | $23.9M | 2.6% | 1.1% | +5.6% |
| 25 | Bellevue Group AGNEW | 155,000 | $23.7M | 0.5% | 1.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.